Published TCIMAIL newest issue No.200 | Product Document Searching Made Easy by 2D Code! | TCI Life Science News December 2025 | [TCIPracticalExample] Suzuki-Miyaura Coupling Using Encapsulated... | Various analytical charts can be searched on each product detail page and Product Document Search (The kinds of analytical charts differ by product)
Maximum quantity allowed is 999
Please select the quantity
CAS RN: 68401-81-0 | Product Number: C2622
Ceftizoxime
×
Purity: >98.0%(T)(HPLC)
Synonyms:
Product Documents:
| Size | Unit Price | Same Day | 2-3 Business Days | Other Lead Time |
Shipping Information
|
|---|---|---|---|---|---|
| 1G |
$119.00
|
6 | 4 | It can be shipped in about 2 weeks after ordering | |
| 5G |
$392.00
|
0 | 5 | Contact Us |
* Please contact our distributors or
TCI
to order our products. The above prices do not include freight cost, customs, and other charges to the destination.
* The storage conditions are subject to change without notice.
Supplemental Product Information:
This product has not been tested for potency and is guaranteed for chemical purity.
| Product Number | C2622 |
Purity / Analysis Method 
|
>98.0%(T)(HPLC) |
| Molecular Formula / Molecular Weight | C__1__3H__1__3N__5O__5S__2 = 383.40 |
| Physical State (20 deg.C) | Solid |
| Storage Temperature
|
Room Temperature (Recommended in a cool and dark place, <15°C) |
| CAS RN | 68401-81-0 |
| Reaxys Registry Number | 5777502 |
| PubChem Substance ID | 160870913 |
| Merck Index (14) | 1951 |
| MDL Number | MFCD00072000 |
Specifications
| Appearance | White to Almost white powder to crystal |
| Purity(HPLC) | min. 98.0 area% |
| Purity(Nonaqueous Titration) | min. 98.0 % |
| Specific rotation [a]20/D | +135.0 to +145.0 deg(C=1、0.1mol/LNaOH3mL+H2O7mL) |
| NMR | confirm to structure |
Properties (reference)
| Melting Point | 227 °C(dec.) |
| Specific Rotation | 139° (C=1,0.1mol/L NaOH 3mL+H2O 7mL) |
GHS
Related Laws:
| RTECS# | XI0367375 |
Transport Information:
| H.S.code* | 2941.90-000 |
Application
Ceftizoxime: A Third Generation Semisynthetic Cephalosporin Antibiotic
Ceftizoxime is a third generation semisynthetic cephalosporin antibiotic, which is chemically synthesized form 7-amino-3-nor-3-cephalosporanic acid. It has a broad spectrum of activity against Gram-positive and Gram-negative aerobic and anaerobic bacteria, and is generally more active against Gram-negative bacteria than the first and second generation cephalosporins.
References
- Antibacterial activity of ceftizoxime, a beta-lactamase-stable cephalosporin
- Ceftizoxime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use
- Ceftizoxime and other third-generation cephalosporins: structure-activity relationships
- Activities of beta-lactam antibiotics against Escherichia coli strains producing extended-spectrum beta-lactamases
- Involvement of MRP4 (ABCC4) in the luminal efflux of ceftizoxime and cefazolin in the kidney
PubMed Literature
Documents
Product Articles
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.